the relevance of idh inhibitors in treating chondrosarcoma
Published 1 year ago • 281 plays • Length 13:34Download video MP4
Download video MP3
Similar videos
-
1:47
an introduction to chondrosarcoma
-
7:10
idh1 mutation in haemato-oncology
-
38:40
brcaness in malignant gliomas: missing the idh1 story - john m. henson, m d, mba
-
19:11
dr. aaron schimmer: clonal hematopoiesis: a pathway to cancer, a pathway to heart disease
-
1:15
outcomes of non-intensive chemotherapy differ for idh1 and idh2-mutated aml
-
3:14
the influence of il6r-adar1-stat3 interplay on mm prognosis
-
11:21
relevance of new data: early tumor shrinkage
-
1:32
cc-220-mm-001: iberdd, ibervd and ibrkd for r/r myeloma
-
2:03
dr. yurgelun discusses germline testing in crc
-
6:26
new data shows that generic drivers are found in benign conditions
-
1:25:29
the era of immuno-oncology in tnbc: implications for breast surgeons
-
1:02:00
mark landers - real-time profiling of tumor heterogeneity in metastatic disease
-
5:07
21st century oncolgy: liver tumors
-
6:49
robotic assisted resection of a right renal hilum tumor
-
2:06:27
advanced ihc for tumors of metastatic unknown origin
-
7:37
zanidatamab for her2-amplified, unresectable, locally advanced or metastatic biliary tract cancer
-
1:09
dr. edward kipreos explains the link between abnormal cell cycles and cancer
-
9:53
holy name medical center's interventional institute